Company Filing History:
Years Active: 2007-2009
Title: Attila Kuba: Innovator in Medical Imaging Technology
Introduction
Attila Kuba is a notable inventor based in Szeged, Hungary. He has made significant contributions to the field of medical imaging technology, particularly in the area of organ segmentation from three-dimensional computed tomography images. With a total of 3 patents to his name, Kuba's work is paving the way for advancements in medical diagnostics.
Latest Patents
Kuba's latest patents include a method and system for automatically segmenting organs from three-dimensional computed tomography images. This innovative method involves selecting a seed, creating an initial surface around the seed, preprocessing the image data, running a deformable surface algorithm on the image data, and post-processing the image data. The selection of the seed can vary based on the organ being analyzed, showcasing the versatility of his approach.
Another significant patent is focused on systems and methods for segmenting an organ in a plurality of images. This system is designed to generate a first set of slices that display images of a subject with the organ. A controller within the system determines a second set of slices that includes the organ, allowing for precise segmentation from the remaining slices. This technology enhances the accuracy of medical imaging and aids in better diagnosis and treatment planning.
Career Highlights
Attila Kuba is currently employed at General Electric Company, where he continues to innovate in the field of medical imaging. His work at GE has allowed him to collaborate with leading experts and contribute to groundbreaking technologies that improve patient care.
Collaborations
Kuba has worked alongside Eors Mate, a fellow innovator in the field. Their collaboration has fostered an environment of creativity and innovation, leading to advancements in medical imaging technologies.
Conclusion
Attila Kuba's contributions to medical imaging technology through his patents and work at General Electric Company highlight his role as a key innovator in the field. His advancements in organ segmentation are set to improve diagnostic capabilities and enhance patient outcomes.